Overview
Founded in 2018 in Antwerp by Roeland Pelgrims, Stijn Verrept, and Bert De Haes, Nobi set out to address one of the most persistent and costly problems in elderly care: falls. Rather than wearables or visible cameras that residents refuse or resent, Nobi built an AI-powered smart light that mounts to the ceiling and operates passively. The device uses optical sensors and on-device AI to detect falls in real time and alert caregivers immediately.
Clinical outcomes reported by Nobi show a 51% average reduction in falls immediately after installation, with some facilities reducing falls by 84% after activating additional prevention features such as predictive risk scoring. These outcomes are significant in a care sector where falls are both a leading cause of serious injury and a major driver of care staff workload.
Nobi raised EUR 13M in a Series A in January 2022. In January 2025, the company closed a EUR 35M Series B that was oversubscribed, co-led by Angelini Ventures and Nexus NeuroTech Ventures. Additional investors in the Series B include Japanese investor 15th Rock, EQT Health Economics, EQT Dementia Fund, PMV, and the co-founders themselves. Total funding to date exceeds EUR 48M.
Media & appearances
- Ben's MentorsYouTubeVerdien Geld Met Je Kennis: De OnlyFans Voor Thought LeadersSmart-lamp fall-detection startup founded by Roeland Pelgrims that Bert invested in and joined; it pivoted to B2B and the US/UK, after which Bert exited amicably but remains a shareholder.
Stated facts & numbers
- Bert cites a statistic that a fall above age 65 leads to death within roughly two years in 70-80% of cases, the problem Nobi addresses. (0:58:54, Ben's Mentors 2025-06-11)
Funding & milestones
2 events found for Nobi · 2022–2025
Series AVenture / equity2 sourcesEUR 13M
Reported amount EUR 13,000,000
Transaction adviser confirms EUR 13,000,000 Series A investment agreed with LSP funds, BNP Paribas Fortis, PMV and existing holders.
InvestorsLSP HoldingLSP Dementia FundPMVBNP Paribas Fortis Private EquitySeries BVenture / equity1 sourceEUR 35M
Reported amount EUR 35,000,000
Dutch company release confirms closed EUR 35m round; localized GBP or USD equivalents are not extra financings.
InvestorsAngelini VenturesNexus NeuroTech Ventures15th RockEQT Health EconomicsEQT Dementia FundPMVRoeland PelgrimsBert De Haes
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Profile narrative
- Series A, EUR 13MJanuary 2022
- Series B, EUR 35MJanuary 2025Angelini Ventures (co-lead), Nexus NeuroTech Ventures (co-lead), 15th Rock, EQT Health Economics, EQT Dementia Fund, PMV
Key people
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.